About MicroRx
Infectious Disease Supercluster
Personnel
COO - Opgenorth
CSO - Beaty
TSM - Headley
General Inquiry
Contact Information
Advisory
Northern Colorado Infectious Disease Research
Downloadable Documents
MicroRx Brochure
Infectious Disease Supercluster
Featured Research
Facilities and Resources
Partnering
Featured Research
Emerging Pathogen Threats
Food Safety
Mycobacterial Disease
Vector-borne Disease
Resources
Animal Models
Product Development and Manufacturing
Research Innovation Center
Intellectual Property
For Researchers
Supercluster Activities
Cluster Leaders
Technology Transfer Process
Legal Agreements
CDA's
Consulting
IDF
Contact Us
Email Registration
General Inquiry
MicroRx Technologies
MicroRx
ID
Title of Technology
06-022
Menaquinone A Inhibitors: Anti Mycobacterial Agents
06-032
Serodiagnostic Antigens for Tuberculosis
07-003
A Toll Receptor 2 Directed TB Vaccine
07-037
Acid and Base Stable Esters: New Linkers for Solid-Phase Organic Synthesis (
Synthesis
or
Libraries
)
07-050
Validation of a Rapid Diagnostic Test for Strangles
07-053
Transferrin Receptor and Ferritin Expression in Primary Lung Lesions of Tuberculosis
07-059
Identification and Characterization of Deliverable RNA Aptamers That Block Late Stage of HIV-1 Replication
08-010
Asymmetrically Substituted Thiourea Derivatives: Potential Anti-TB Therapeutic Agents
07-069M
A Drug-Sensitized Pseudomonas Aeruginosa Strain Useful for Drug Discovery
08-012
Improved Diagnostic Methods for M. Tuberculosis and M. Leprae
97-037
Early Detection of Tuberculosis Using Culture Filtrate Proteins of Mycobacterium tuberculosis in Serological Assays
Copyright © 2007 MicroRx. All rights reserved.